Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model.

Sixten Borg, Ulf Persson, Kristina Allikmets, Karin Ericsson

Research output: Contribution to journalArticlepeer-review

10 Citations (SciVal)
Original languageEnglish
Pages (from-to)1947-59
JournalClinical Therapeutics
Volume28
Issue number11
DOIs
Publication statusPublished - 2006

Subject classification (UKÄ)

  • Pharmaceutical Sciences

Cite this